Both in Pharmaceuticals
PTC Therapeutics vs Travere Therapeutics
Over the past year PTCT returned −6.3% and TVTX returned +68.0%; their daily moves had a correlation of 0.37.
PTCT −6.3% TVTX +68.0%Growth of $1, one year, split-adjusted
| Metric | PTCT | TVTX |
|---|---|---|
| Price | $62.88 | $50.00 |
| Market cap | $5.25B | $4.71B |
| Today | +1.27% | −1.73% |
| 1 month | −3.2% | −16.7% |
| 6 months | −2.6% | +24.7% |
| Year to date | −17.2% | +30.9% |
| 1 year | −6.3% | +68.0% |
| Revenue growth (YoY) | +101.5% | +48.2% |
| Gross margin | 94.5% | 98.7% |
| Net margin | 23.2% | −20.5% |
| P/E (TTM) | — | — |
| Price / sales | 5.2× | 8.0× |
| Net cash | $1.63B | -$113.6M |
| Dividend yield | — | — |
| Volatility (60d) | 34.5% | 42.9% |
| Short % of float | 10.5% | 12.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).